AMBALALSA
NSEAmbalal Sarabhai Enterprises Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹31.07
0.17 (0.54%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹238 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹30.3+2.5%
52W High₹38.5-19.3%
Current Price
₹31.07
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹24.86
Upper Circuit₹37.28
Reference Price
₹31.07
Investment Checklist
Trend: Price below most MAs — downtrend
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Composite score -7.58 (NEUTRAL) with 43.2% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-11
Confidence
43%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
32.09
EMA50
32.55
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹33.59
₹36.15
₹38.50
Support (Below)
₹31.03
₹30.61
₹30.30
Volume Analysis
TrendDECREASING
Change-36.70%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹30.76
3% Risk₹30.14
5% Risk₹29.52
7% Risk (Custom)
₹28.90Technical Levels
1x ATR (Volatility)₹29.52
2x ATR (Swing)₹27.97
3x ATR (Trend)₹26.42
Immediate Support₹31.03
Financials
Financial data not available
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.7 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.6 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 22.8 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.3 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.1 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.1 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 25.7 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 93.4 | ₹83.02K Cr mid Cap | |
| Ambalal Sarabhai Enterprises Limited | ₹31.07 | -0.54% | — | ₹238 Cr small Cap |
Corporate Information
Latest News
News for AMBALALSA
View AllNEWS
positive
Business Standard - Markets 50d ago
Ambalal Sarabhai Enterprises reports consolidated net profit of Rs 6.50 crore in the March 2026 quarter
Sales rise 1.05% to Rs 65.49 crore
AMBALALSAHealthcare